PROCÉDÉS ET COMPOSITIONS DE TRAITEMENT DU SYNDROME DE HUNTER

• 收藏
• 分享

专利权人:

Green Cross Corporation;Medigenebio Corporation

发明人:

申请号：

EP16882018.1

公开号：

EP3397270A4

申请日:

2016.12.21

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention provides, among other things, compositions and methods for CNS delivery of Idursulfase-beta, a human recombinant iduronate-2-sulfatase protein, for effective treatment of Hunter Syndrome. The compositions and methods provided by the present invention effectively reduce symptoms not only in brain and spinal cord but also in peripheral tissues including heart, liver, spleen, lung, and kidney.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/